1. Home
  2. BCML vs CMPX Comparison

BCML vs CMPX Comparison

Compare BCML & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BayCom Corp

BCML

BayCom Corp

HOLD

Current Price

$32.02

Market Cap

348.1M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.04

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCML
CMPX
Founded
2004
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
348.1M
752.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BCML
CMPX
Price
$32.02
$5.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$32.00
$13.44
AVG Volume (30 Days)
21.6K
2.2M
Earning Date
01-22-2026
11-05-2025
Dividend Yield
3.76%
N/A
EPS Growth
N/A
N/A
EPS
2.10
N/A
Revenue
$94,896,000.00
N/A
Revenue This Year
$0.51
N/A
Revenue Next Year
$10.33
N/A
P/E Ratio
$15.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.22
$1.33
52 Week High
$33.15
$5.86

Technical Indicators

Market Signals
Indicator
BCML
CMPX
Relative Strength Index (RSI) 62.12 50.95
Support Level $27.94 $4.83
Resistance Level $33.15 $5.19
Average True Range (ATR) 0.92 0.29
MACD 0.20 -0.08
Stochastic Oscillator 73.22 23.24

Price Performance

Historical Comparison
BCML
CMPX

About BCML BayCom Corp

BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: